Explore more publications!

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on December 17, 2025

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
TadHealth Awarded San Diego County Office of Education Contract; School Districts to Begin CYBHI Billing in January 2026
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China  for Patients with Obstructive Hypertrophic Cardiomyopathy
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions